Intranasal Ketorolac Trial

NCT06083571 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
41
Enrollment
OTHER
Sponsor class

Stopped The eligibility criteria within the protocol led to the exclusion of a large proportion of potential participants, thereby limiting enrollment. During the conceptualization phase, the number of eligible patients was overestimated.

Conditions

Interventions

Sponsor

Washington University School of Medicine

Collaborators